DK3674309T3 - Disaccharid syntetiske lipidforbindelser og anvendelser heraf - Google Patents
Disaccharid syntetiske lipidforbindelser og anvendelser heraf Download PDFInfo
- Publication number
- DK3674309T3 DK3674309T3 DK20157427.4T DK20157427T DK3674309T3 DK 3674309 T3 DK3674309 T3 DK 3674309T3 DK 20157427 T DK20157427 T DK 20157427T DK 3674309 T3 DK3674309 T3 DK 3674309T3
- Authority
- DK
- Denmark
- Prior art keywords
- lipid compounds
- synthetic lipid
- disaccharide
- disaccharide synthetic
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261623393P | 2012-04-12 | 2012-04-12 | |
| US13/842,424 US9241988B2 (en) | 2012-04-12 | 2013-03-15 | Disaccharide synthetic lipid compounds and uses thereof |
| EP13775926.2A EP2836499B1 (en) | 2012-04-12 | 2013-04-12 | Disaccharide synthetic lipid compounds and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3674309T3 true DK3674309T3 (da) | 2024-11-25 |
Family
ID=49325307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK20157427.4T DK3674309T3 (da) | 2012-04-12 | 2013-04-12 | Disaccharid syntetiske lipidforbindelser og anvendelser heraf |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9241988B2 (OSRAM) |
| EP (2) | EP3674309B1 (OSRAM) |
| JP (3) | JP6271510B2 (OSRAM) |
| CN (2) | CN107412766A (OSRAM) |
| CA (1) | CA2870008C (OSRAM) |
| DK (1) | DK3674309T3 (OSRAM) |
| ES (2) | ES2992314T3 (OSRAM) |
| IN (1) | IN2014DN09392A (OSRAM) |
| WO (1) | WO2013155448A1 (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2657392T3 (es) | 2006-09-26 | 2018-03-05 | Infectious Disease Research Institute | Composición de vacuna que contiene un adyuvante sintético |
| US9241988B2 (en) * | 2012-04-12 | 2016-01-26 | Avanti Polar Lipids, Inc. | Disaccharide synthetic lipid compounds and uses thereof |
| SMT201800368T1 (it) | 2012-05-16 | 2018-09-13 | Immune Design Corp | Vaccini per l'infezione da virus-2 herpes simplex |
| US20150086592A1 (en) | 2013-09-25 | 2015-03-26 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9149522B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9504743B2 (en) | 2013-09-25 | 2016-11-29 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9149521B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| CA2960948C (en) * | 2014-09-12 | 2023-04-04 | Bestewil Holding B.V. | Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby |
| EP3270962A4 (en) * | 2015-03-17 | 2018-08-22 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| EP3069729A1 (en) * | 2015-03-17 | 2016-09-21 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| EP3849521A1 (en) | 2018-09-14 | 2021-07-21 | Massachusetts Institute Of Technology | Nanoparticle vaccine adjuvant and methods of use thereof |
| CA3118692A1 (en) | 2018-11-06 | 2020-05-14 | Alsatech, Inc. | Cell-based gene therapy for neurodegenerative diseases |
| WO2020109365A1 (en) | 2018-11-29 | 2020-06-04 | Glaxosmithkline Biologicals Sa | Methods for manufacturing an adjuvant |
| WO2021099982A1 (en) | 2019-11-22 | 2021-05-27 | Glaxosmithkline Biologicals Sa | Dosage and administration of a bacterial saccharide glycoconjugate vaccine |
| US20230190920A1 (en) | 2021-12-19 | 2023-06-22 | Massachusetts Institute Of Technology | Compositions and methods for long-lasting germinal center responses to a priming immunization |
| EP4590402A1 (en) | 2022-09-21 | 2025-07-30 | Wisconsin Alumni Research Foundation | Compositions and methods to enhance therapeutic efficacy of cancer therapies |
| WO2024151642A1 (en) * | 2023-01-09 | 2024-07-18 | University Of Maryland, Baltimore | Engineered anti-nociceptive-los competitive tlr4 ligands and methods for treating pain while maintaining immunosufficiency |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5066794A (en) | 1984-08-24 | 1991-11-19 | Daiichi Pharmaceutical Co., Ltd. | Process for preparing a disaccharide derivative |
| GR860379B (en) * | 1985-02-22 | 1986-06-11 | Akzo Nv | Novel disaccharide and trisaccharide derivatives of the lipid a type |
| JP2535048B2 (ja) | 1988-02-29 | 1996-09-18 | 第一製薬株式会社 | 新規ジサッカライド誘導体及びその塩 |
| JPH06206893A (ja) * | 1992-09-07 | 1994-07-26 | Suntory Ltd | 新規なジサッカライド誘導体 |
| US5654289A (en) | 1993-09-07 | 1997-08-05 | Suntory Limited | Disaccharide derivative |
| ES2149340T3 (es) * | 1993-11-17 | 2000-11-01 | Om Pharma | Disacaridos de glucosamina, metodo para su preparacion, composicion farmaceutica que los comprende, y su uso. |
| JPH10152497A (ja) * | 1996-09-30 | 1998-06-09 | Otsuka Pharmaceut Factory Inc | ヘリコバクター・ピロリのリピドａ |
| US6630161B1 (en) * | 1998-05-07 | 2003-10-07 | Ribi Immunochem Research, Inc. | Adjuvant composition and methods for its use |
| PT1096954E (pt) * | 1998-07-14 | 2004-12-31 | Wyeth Corp | Composicoes de adjuvante e vacina contendo monofosforil-lipido a |
| US20020022032A1 (en) * | 1999-04-23 | 2002-02-21 | Curry Patrick Mark | Immuno-adjuvant PDT treatment of metastatic tumors |
| EP1232168B1 (en) | 1999-11-15 | 2011-08-03 | Oncothyreon Inc. | Synthetic lipid-a analogs and uses thereof |
| KR100829674B1 (ko) * | 2000-05-19 | 2008-05-16 | 코릭사 코포레이션 | 단당류 또는 이당류계 화합물을 이용한 전염성 및 다른질병의 예방 및 치료 방법 |
| CN1907289A (zh) * | 2000-05-19 | 2007-02-07 | 科里克萨有限公司 | 用单糖和二糖类化合物预防和治疗传染病和其他疾病的方法 |
| US20030031684A1 (en) * | 2001-03-30 | 2003-02-13 | Corixa Corporation | Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid a (3D-MLA) |
| GB0420634D0 (en) * | 2004-09-16 | 2004-10-20 | Glaxosmithkline Biolog Sa | Vaccines |
| US7622128B2 (en) * | 2005-12-13 | 2009-11-24 | University Of Washington | Porphyromonas gingivalis 1435/1449 LPS as an immune modulator |
| WO2008059307A2 (en) | 2006-11-16 | 2008-05-22 | Om Pharma | Functionalized beta 1,6 glucosamine disaccharides and process for their preparation |
| US8563523B2 (en) | 2007-09-07 | 2013-10-22 | University Of Georgia Research Foundation, Inc. | Synthetic lipid A derivative |
| ES2719406T3 (es) * | 2007-12-24 | 2019-07-10 | Id Biomedical Corp Quebec | Antígenos recombinantes del VSR |
| US9241988B2 (en) * | 2012-04-12 | 2016-01-26 | Avanti Polar Lipids, Inc. | Disaccharide synthetic lipid compounds and uses thereof |
-
2013
- 2013-03-15 US US13/842,424 patent/US9241988B2/en active Active
- 2013-04-12 IN IN9392DEN2014 patent/IN2014DN09392A/en unknown
- 2013-04-12 ES ES20157427T patent/ES2992314T3/es active Active
- 2013-04-12 EP EP20157427.4A patent/EP3674309B1/en active Active
- 2013-04-12 CN CN201710534045.0A patent/CN107412766A/zh active Pending
- 2013-04-12 CA CA2870008A patent/CA2870008C/en active Active
- 2013-04-12 EP EP13775926.2A patent/EP2836499B1/en active Active
- 2013-04-12 CN CN201380026285.XA patent/CN104470938B/zh active Active
- 2013-04-12 JP JP2015505953A patent/JP6271510B2/ja active Active
- 2013-04-12 WO PCT/US2013/036425 patent/WO2013155448A1/en not_active Ceased
- 2013-04-12 ES ES13775926T patent/ES2787876T3/es active Active
- 2013-04-12 DK DK20157427.4T patent/DK3674309T3/da active
-
2016
- 2016-01-26 US US15/006,938 patent/US10143744B2/en active Active
-
2017
- 2017-12-26 JP JP2017248795A patent/JP6764396B2/ja active Active
-
2020
- 2020-05-26 JP JP2020091157A patent/JP7189906B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6764396B2 (ja) | 2020-09-30 |
| US9241988B2 (en) | 2016-01-26 |
| JP6271510B2 (ja) | 2018-01-31 |
| US10143744B2 (en) | 2018-12-04 |
| ES2992314T3 (es) | 2024-12-11 |
| CN107412766A (zh) | 2017-12-01 |
| WO2013155448A1 (en) | 2013-10-17 |
| EP3674309B1 (en) | 2024-09-11 |
| CN104470938A (zh) | 2015-03-25 |
| EP3674309A1 (en) | 2020-07-01 |
| CA2870008C (en) | 2021-05-04 |
| CA2870008A1 (en) | 2013-10-17 |
| US20130273149A1 (en) | 2013-10-17 |
| JP2020147579A (ja) | 2020-09-17 |
| CN104470938B (zh) | 2017-07-28 |
| US20160136271A1 (en) | 2016-05-19 |
| EP2836499A4 (en) | 2015-11-25 |
| EP2836499B1 (en) | 2020-02-26 |
| ES2787876T3 (es) | 2020-10-19 |
| JP2018070652A (ja) | 2018-05-10 |
| EP2836499A1 (en) | 2015-02-18 |
| JP2015512946A (ja) | 2015-04-30 |
| HK1207383A1 (en) | 2016-01-29 |
| JP7189906B2 (ja) | 2022-12-14 |
| IN2014DN09392A (OSRAM) | 2015-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3674309T3 (da) | Disaccharid syntetiske lipidforbindelser og anvendelser heraf | |
| EP2763896A4 (en) | UNMANUFACTURED AIRCRAFT WITH SEVERAL ROTORS | |
| DK2859055T3 (da) | Polymercoatings | |
| DK2825087T3 (da) | Otoscanner | |
| DK2839013T3 (da) | Ikke-disruptiv-gen-targetering | |
| DK3942944T3 (da) | Ernæringssammensætning | |
| EP2805877A4 (en) | UNDER HOOD | |
| DE112012006109A5 (de) | Okklusionsschienenanordnung | |
| DK2873977T3 (da) | Dobbeltdækker-rørdispenser | |
| DK2854722T3 (da) | Stomipose | |
| EP2911305A4 (en) | MULTIPLEXER | |
| DK2825157T3 (da) | Aminosyrelipider | |
| EP2801315A4 (en) | SCANNING ENDOSCOPE DEVICE | |
| DE112012006214T8 (de) | Wulstringwickler | |
| DK2831122T3 (da) | Anthocyanidin-kompleks | |
| EP2878228A4 (en) | EASEL | |
| PL3260761T3 (pl) | Wielobarwna tablica świetlna | |
| DK2885638T3 (da) | Molekylenet | |
| DE112012005566T8 (de) | Seltenerdnanoverbundmagnet | |
| DK2858657T3 (da) | Feijoafrugtekstrakt | |
| BR302012003846S1 (pt) | Configuração aplicada em almofada | |
| HRP20190033T1 (hr) | Pripravak | |
| DE102013212400A8 (de) | Abdeckplattenstützbaugruppe | |
| DE202012013401U8 (de) | Bioextruder | |
| DK2897570T3 (da) | Spin-elueringsrør |